{"id":48518,"date":"2026-08-27T19:58:13","date_gmt":"2026-08-27T14:28:13","guid":{"rendered":"https:\/\/www.editage.com\/insights\/?p=48518"},"modified":"2026-08-28T01:52:09","modified_gmt":"2026-08-27T20:22:09","slug":"what-the-end-of-nih-paylines-means-for-grant-writers","status":"publish","type":"post","link":"https:\/\/www.editage.com\/insights\/what-the-end-of-nih-paylines-means-for-grant-writers","title":{"rendered":"What the End of NIH Paylines Means for Grant Writers"},"content":{"rendered":"\n

The National Institutes of Health have proposed changes to the way that grants are reviewed and scores are reported. With the end of paylines, is a good peer review score still enough to get funded? What should grant writers know before submitting the next grant? What to early career researchers, especially, need to be aware of?<\/p>\n\n\n\n

Researchers are asking: <\/p>\n\n\n\n

\n

“What does a strong application need to do to have a reasonable chance of being funded?”<\/p>\n<\/blockquote>\n\n\n\n

With NIH proposing to make more nuanced decisions, stability, predictability and clarity will be needed to interpret the new Unified Funding Strategy approach. Reforms take time to get integrated into the workflow. However, there are advantages to flexibility that open up opportunities <\/strong>for innovative or emerging research areas, give space for early career researchers to enter the funding arena, respond to public health priorities, and remain agile by allocating funds where required. <\/p>\n\n\n\n

What this means for researchers<\/h2>\n\n\n\n